Journal of Pharmacy and Pharmacology · 1972 · 152 citations · 5 references
PharmacyPharmacokineticsPharmacologyBioavailabilityExcretionPharmaceutical ToxicologyDrug DispositionInhalation Dosage FormsPulmonary PharmacokineticsInhaled Drug PharmacokineticsMetabolic Half-life
Abstract The fate of [14C]disodium cromoglycate (DSCG) has been examined in 12 asthmatic patients. Maximum plasma concentrations (mean 9.2 ng/ml) were obtained within 15 min of inhaling DSCG (20 mg) and the average plasma half-life was 81 min. Although absorption from the lung is rapid, most of the inhaled dose is swallowed. Only 2.0% of the dose was excreted in the urine, and 84% was recovered from the faeces. DSCG is poorly absorbed from the gastrointestinal tract, only 0.4 % of an oral dose (20 mg) appeared in the 24 h urine and 83 % was recovered from the faeces. Intravenous administration of DSCG resulted in approximately equal amounts (30–50% of dose) being excreted via the urine and faeces. No metabolites of DSCG were detected chromatographically.
5
INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTS
J. Pepys, Frederick E. Hargreave, Moira Chan et al. · The Lancet · 1968 · 299 citations